Global Knee Cartilage Repair Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Treatment Modality;

Arthroscopic Chondroplasty, Osteochondral Grafts Transplantation, Autologous Chondrocyte Implantation, Cell-Based Cartilage Resurfacing, Implants Transplant, and Microfracture.

By Application;

Arthroscopic Chondroplasty, Autologous Chondrocyte Implantation, Osteochondral Grafts Transplantation, Cell-based Cartilage Resurfacing, Implants Transplant, Microfracture, and Others.

By End Users;

Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn825720067 Published Date: February, 2025 Updated Date: March, 2025

Introduction

Global Knee Cartilage Repair Market (USD Million), 2021 - 2031

In the year 2024, the Global Knee Cartilage Repair Market was valued at USD 717.85 million. The size of this market is expected to increase to USD 965.17 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.3%.

The global knee cartilage repair market is witnessing significant growth attributed to the escalating prevalence of knee injuries and osteoarthritis on a global scale. As an essential component of joint health, knee cartilage plays a crucial role in facilitating smooth joint movement and preventing bone-on-bone contact. With the rise in sports-related injuries, aging populations, and increasing obesity rates, the incidence of knee cartilage damage and degenerative joint diseases continues to surge, propelling the demand for effective treatment options.

Advancements in medical technology and surgical techniques have revolutionized the landscape of knee cartilage repair, offering patients a spectrum of innovative solutions to address their orthopedic concerns. From traditional procedures like microfracture and autologous chondrocyte implantation (ACI) to cutting-edge techniques such as matrix-induced autologous chondrocyte implantation (MACI) and scaffold-based therapies, healthcare providers now have a diverse arsenal to combat knee cartilage defects. These advancements not only aim to alleviate symptoms but also strive to restore joint function and delay the progression of osteoarthritis, fostering a paradigm shift towards knee preservation strategies.

Despite the remarkable progress in treatment modalities, the knee cartilage repair market faces several challenges. High procedural costs, limited access to specialized healthcare facilities, and stringent regulatory hurdles pose significant barriers to market growth. Moreover, concerns regarding the long-term efficacy and durability of cartilage repair treatments continue to linger, prompting ongoing research efforts to refine existing techniques and develop next-generation solutions. Nevertheless, with the growing emphasis on personalized medicine, integration of regenerative therapies, and expanding market presence in emerging economies, the global knee cartilage repair market is poised for sustained expansion in the foreseeable future.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Treatment Modality
    2. Market Snapshot, By Application
    3. Market Snapshot, By End Users
    4. Market Snapshot, By Region
  4. Global Knee Cartilage Repair Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Prevalence of Knee Injuries and Osteoarthritis
        2. Increasing Awareness and Early Intervention
        3. Advancements in Surgical Techniques and Technologies
        4. Demand for Minimally Invasive Procedures
      2. Restraints
        1. High Procedure Costs
        2. Limited Availability of Skilled Surgeons
        3. Stringent Regulatory Requirements
        4. Post-operative Complications
      3. Opportunities
        1. Emerging Markets Expansion
        2. Integration of Regenerative Medicine
        3. Collaborations and Partnerships
        4. Personalized Medicine Adoption
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Knee Cartilage Repair Market, By Treatment Modality, 2021 - 2031 (USD Million)
      1. Arthroscopic Chondroplasty
      2. Osteochondral Grafts Transplantation
      3. Autologous Chondrocyte Implantation
      4. Cell-based Cartilage Resurfacing
      5. Implants Transplant and Microfracture
    2. Global Knee Cartilage Repair Market, By Application, 2021 - 2031 (USD Million)
      1. Arthroscopic Chondroplasty
      2. Autologous Chondrocyte Implantation
      3. Osteochondral Grafts Transplantation
      4. Cell-based Cartilage Resurfacing
      5. Implants Transplant
      6. Microfracture
      7. Others
    3. Global Knee Cartilage Repair Market, By End Users, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Orthopedic Clinics
      4. Others
    4. Global Knee Cartilage Repair Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. B. Braun Melsungen AG
      2. Histogenics Corporation
      3. ISTO Technologies Inc
      4. MEDIPOST Co Ltd
      5. Osiris Therapeutics Inc
      6. Smith & Nephew plc
      7. Stryker Corporation
      8. TiGenix NV
      9. Vericel Corporation
      10. Zimmer Biomet Holdings Inc
      11. DePuy Synthes
  7. Analyst Views
  8. Future Outlook of the Market